pravastatin has been researched along with Coronary Thrombosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kerensky, RA; Monroe, VS; Pepine, CJ; Rivera, E; Smith, KM | 1 |
| Ambrose, JA; Badimon, JJ; Dangas, G; Fallon, JT; Fier, C; Levine, D; Meraj, P; Shao, JH; Smith, DA; Unger, AH | 1 |
| Giri, S; Moyna, NM; Thompson, PD; Waters, DD; Weber, KM; White, CM | 1 |
1 review(s) available for pravastatin and Coronary Thrombosis
| Article | Year |
|---|---|
Pharmacologic plaque passivation for the reduction of recurrent cardiac events in acute coronary syndromes.
Topics: Abciximab; Acute Disease; Angina, Unstable; Antibodies, Monoclonal; C-Reactive Protein; Coronary Artery Disease; Coronary Thrombosis; Disease Progression; Endothelium, Vascular; Enoxaparin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin Fab Fragments; Macrophages; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pravastatin; Randomized Controlled Trials as Topic; Secondary Prevention; Severity of Illness Index | 2003 |
2 trial(s) available for pravastatin and Coronary Thrombosis
| Article | Year |
|---|---|
Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile.
Topics: Aged; Aspirin; Blood Coagulation Factors; Cholesterol, LDL; Coronary Thrombosis; Double-Blind Method; Female; Fibrinolytic Agents; Follow-Up Studies; Hemostasis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipoprotein(a); Male; Middle Aged; Pravastatin; Prospective Studies; Treatment Outcome | 1999 |
The effects of hydroxy-methyl-glutaryl co-enzyme A reductase inhibitors on platelet thrombus formation.
Topics: Aged; Analysis of Variance; Blood Platelets; Chi-Square Distribution; Coronary Artery Disease; Coronary Thrombosis; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pravastatin; Probability; Reference Values; Simvastatin; Treatment Outcome | 2002 |